相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia
Ali T. Taher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients
John B. Porter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study
Khaled M. Musallam et al.
HAEMATOLOGICA (2014)
Identification of erythroferrone as an erythroid regulator of iron metabolism
Leon Kautz et al.
NATURE GENETICS (2014)
An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
Michael Dussiot et al.
NATURE MEDICINE (2014)
Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study
Sant-Rayn Pasricha et al.
BLOOD (2013)
Combined chelation therapy with deferasirox and deferoxamine in thalassemia
Ashutosh Lal et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Evaluation of the 5 mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia
Khaled M. Musallam et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Clinical Manifestations of α-Thalassemia
Elliott P. Vichinsky
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study
Paolo Ricchi et al.
ANNALS OF HEMATOLOGY (2012)
Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study
Ali T. Taher et al.
BLOOD (2012)
The definition and epidemiology of non-transfusion-dependent thalassemia
David J. Weatherall
BLOOD REVIEWS (2012)
The Hemoglobin E Thalassemias
Suthat Fucharoen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
β-Thalassemia Intermedia: A Clinical Perspective
Khaled M. Musallam et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Optimal management of β thalassaemia intermedia
Ali T. Taher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia
Khaled M. Musallam et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Heterogeneity of Hemoglobin H Disease in Childhood
Ashutosh Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia
Sara Gardenghi et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
α-thalassaemia
Cornelis L. Harteveld et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Beta-thalassemia
Renzo Galanello et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies
Ali Taher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia
Ali Taher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Quantification of hepcidin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Sukhvinder S. Bansal et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2009)
Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia
Ali Taher et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial
Patrick B. Walter et al.
HAEMATOLOGICA (2008)
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Toshihiko Tanno et al.
NATURE MEDICINE (2007)
Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients
Zahra Pakbaz et al.
PEDIATRIC BLOOD & CANCER (2007)
Age-related changes in adaptation to severe anemia in childhood in developing countries
Angela O'Donnell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Liver iron concentrations and urinary hepcidin in β-thalassemia
Raffaella Origa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Haemoglobin E β thalassaemia in Sri Lanka
A Premawardhena et al.
LANCET (2005)
LPI-labile plasma iron in iron overload
ZI Cabantchik et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
TG St Pierre et al.
BLOOD (2005)
Labile plasma iron in iron overload: redox activity and susceptibility to chelation
BP Esposito et al.
BLOOD (2003)
Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method
O Loréal et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
